Active substance
Normal human immunoglobulin
- SFDA 26
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION | 5 % | Solution for infusion · Intravenous use | 1 Vial | SAR 224.15 | Biological · Prescription | Instituto Grifols, S.A | Valid |
| FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION | 5 % | Solution for infusion · Intravenous use | 1 Vial | SAR 1120.70 | Biological · Prescription | Instituto Grifols, S.A | Valid |
| FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION | 5 % | Solution for infusion · Intravenous use | 1 Vial | SAR 2241.40 | Biological · Prescription | Instituto Grifols, S.A | Valid |
| FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION | 5 % | Solution for infusion · Intravenous use | 1 Vial | SAR 8965.60 | Biological · Prescription | Instituto Grifols, S.A | Valid |
| FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION | 5 % | Solution for infusion · Intravenous use | 1 Vial | SAR 4482.80 | Biological · Prescription | INSTITUTO GRIFOLS | Valid |
| GAMUNEX 10% solution for infusion | 10 % | Solution for infusion · Intravenous, Subcutaneous | 1 Vial | SAR 1120.70 | Biological · Prescription | GRIFOLS THERAPEUTICS INC | Valid |
| GAMUNEX 10% solution for infusion | 10 % | Solution for infusion · Intravenous, Subcutaneous | 1 Vial | SAR 2241.40 | Biological · Prescription | GRIFOLS THERAPEUTICS INC | Valid |
| GAMUNEX 10% solution for infusion | 10 % | Solution for infusion · Intravenous, Subcutaneous | 1 Vial | SAR 4482.80 | Biological · Prescription | GRIFOLS THERAPEUTICS INC | Valid |
| KIOVIG 100MG/ML SOLUTION FOR INFUSION | 100 mg/ml | Solution for infusion · Intravenous use | 1 Vial | SAR 8965.60 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| KIOVIG 100MG/ML SOLUTION FOR INFUSION | 100 mg/ml | Solution for infusion · Intravenous use | 1 Vial | SAR 4482.80 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| KIOVIG 100MG/ML SOLUTION FOR INFUSION | 100 mg/ml | Solution for infusion · Intravenous use | 1 Vial | SAR 2241.40 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| KIOVIG 100MG/ML SOLUTION FOR INFUSION | 100 mg/ml | Solution for infusion · Intravenous use | 1 Vial | SAR 1120.70 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| KIOVIG 100MG/ML SOLUTION FOR INFUSION | 100 mg/ml | Solution for infusion · Intravenous use | 1 Vial | SAR 448.30 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| OCTAGAM 100 mg/ml solution for infusion | 100 mg/ml | Solution · Intravenous use | 1 Vial | SAR 896.55 | Biological · Prescription | OCTAPHARMA | Valid |
| OCTAGAM 100 mg/ml solution for infusion | 100 mg/ml | Solution · Intravenous use | 1 Vial | SAR 2241.40 | Biological · Prescription | OCTAPHARMA | Valid |
| OCTAGAM 100 mg/ml solution for infusion | 100 mg/ml | Solution · Intravenous use | 1 Vial | SAR 4482.80 | Biological · Prescription | OCTAPHARMA | Valid |
| OCTAGAM 100 mg/ml solution for infusion | 100 mg/ml | Solution · Intravenous use | 1 Vial | SAR 8965.60 | Biological · Prescription | OCTAPHARMA | Valid |
| OCTAGAM 1GM-20ML I.V | 1 g | Solution · Intravenous use | 1 Vial | SAR 1120.70 | Biological · Prescription | OCTAPHARMA | Valid |
| OCTAGAM 1GM-20ML I.V | 1 g | Solution · Intravenous use | 1 Bottle | SAR 2241.40 | Biological · Prescription | OCTAPHARMA | Valid |
| INTRAGLOBIN 250MG | 250 mg | Solution for injection · Intravenous use | 1 Vial | SAR 79.55 | Biological · Prescription | BIOTEST | Withdrawn by MAH · Not Marketed |
| INTRAGLOBIN 500MG+DILUENT | 500 mg | Solution for injection · Intravenous use | 1 Vial | SAR 159.15 | Biological · Prescription | BIOTEST | Withdrawn by MAH · Not Marketed |
| OCTAGAM 1GM-20ML I.V | 1 g | Solution · Intravenous use | 1 Vial | SAR 448.30 | Biological · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| OCTAGAM 1GM-20ML I.V | 1 g | Solution · Intravenous use | 1 Ampoule | SAR 4482.80 | Biological · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| VIGAM LIQUID 5% I.V BOTTLE | 5 % | Solution · Intravenous use | 1 Bottle | SAR 2241.40 | Biological · Prescription | BIO-PRODUCT LAB | Withdrawn by MAH · Not Marketed |
| VIGAM LIQUID 5% I.V BOTTLE | 5 % | Solution · Intravenous use | 1 Bottle | SAR 1120.70 | Biological · Prescription | BIO-PRODUCT LAB | Withdrawn by MAH · Not Marketed |
1 more — full table
Indications — CHI Daman Drug Formulary
ACQUIRED HEMOPHILIA; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGIITIS; GUILLAIN-BARRE SYNDROME; MYASTHENIA GRAVIS; MYOSITIS; OPTIC NEURITIS; PEMPHIGUS; POMPE DISEASE (IOPD/LOPD); RENAL TRANSPLANT; SJOGREN'S SYNDROME
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.